Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-09-30 Tax Withholding | 2020-10-01 4:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.533 | 185,393 (Direct) | View |
2020-08-31 Tax Withholding | 2020-09-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.6194 | 185,759 (Direct) | View |
2020-08-20 Tax Withholding | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 3,759 | $0.6476 | 186,125 (Direct) | View |
2020-08-19 Exercise | 2020-08-21 7:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 11,250 | $0 | 186,125 (Direct) | View |
2020-07-31 Tax Withholding | 2020-08-04 4:09 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.76 | 178,634 (Direct) | View |
2020-06-30 Tax Withholding | 2020-07-02 4:07 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.6746 | 179,000 (Direct) | View |
2020-05-31 Tax Withholding | 2020-06-03 06:06 am | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $1.14 | 179,366 (Direct) | View |
2020-04-30 Tax Withholding | 2020-05-04 6:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.5483 | 179,732 (Direct) | View |
2020-03-31 Tax Withholding | 2020-04-02 5:49 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.575 | 180,098 (Direct) | View |
2020-02-28 Tax Withholding | 2020-03-03 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $1.35 | 180,464 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 8:28 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 315,000 | $0 | 390,830 (Direct) | View |
2020-01-31 Tax Withholding | 2020-02-04 8:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 3,892 | $1.35 | 155,552 (Direct) | View |